logo

For the Inventor, By the Inventor

Staten Island, NY, United States of America

Henry Joshua

This inventor holds 13 USPTO granted patents, plus 1 CIPO patent. Top assignees: Merck + Co., Inc., Other. Active years: 1981-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Henry Joshua. Retrieved from https://idiyas.com/inventor/henry-joshua

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 100.0


Average Co-Inventor Count = 2.5

ph-index = 10

Forward Citations = 189(Granted Patents)


Location History:

  • Elizabeth, NJ (US) (1982)
  • Staten Island, NY (US) (1981 - 1994)

Company Filing History:

goldMedal11 out of 4,770 
 
Merck + Co., Inc.
 patents
silverMedal2 out of 834,570 
Other
 patents

Years Active: 1981-1994

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 5286895 - Cholesterol lowering compounds (1994-02-15),
2. 5262435 - Cholesterol lowering compounds (1993-11-16),
3. 5202309 - Antibiotic cyclopeptide fermentation product (1993-04-13),
4. 5064856 - Novel HMG-CoA synthase inhibitors (1991-11-12),
5. 5021453 - 3-keto HMG-CoA reductase inhibitors (1991-06-04),
6. 4968693 - 3-keto HMG-COA reductase inhibitors (1990-11-06),
7. 4966695 - High pressure liquid chromatography column jacket (1990-10-30),
8. 4714711 - 6-hydroxy-2(2-hydroxy-4-methoxyphenyl)benzofuran derivatives to inhibit (1987-12-22),
9. 4704400 - Medicarpin derivatives and analogs (1987-11-03),
10. 4523934 - Filter-degasser (1985-06-18),
11. 4420491 - Hypocholesteremic fermentation products and process of preparation (1983-12-13),
12. 4339453 - Antimicrobial aminopyrimidinium salts (1982-07-13),
13. 4294846 - Hypocholesteremic fermentation products and products of preparation (1981-10-13),

Title: The Innovations of Henry Joshua

Introduction

Henry Joshua is a notable inventor based in Staten Island, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of cholesterol-lowering compounds. With a total of 13 patents to his name, his work has had a considerable impact on medical treatments for hypercholesterolemia.

Latest Patents

Among his latest patents, Joshua has isolated an acyclic tricarboxylic compound from a culture of MF5453. This compound and its derivatives are recognized as active squalene synthetase inhibitors, proving useful in the treatment of hypercholesterolemia. Additionally, he has developed a new Zaragozic acid analog, also isolated from a culture of MF5453, which shares similar properties and applications in lowering cholesterol levels.

Career Highlights

Throughout his career, Henry Joshua has worked with prominent companies, including Merck & Company, Inc. His innovative research and dedication to improving health outcomes have established him as a respected figure in the pharmaceutical industry.

Collaborations

Joshua has collaborated with notable colleagues such as George E Albers-Schonberg and Maria B Lopez. Their combined expertise has contributed to the advancement of research in cholesterol-lowering treatments.

Conclusion

Henry Joshua's contributions to the field of pharmaceuticals, particularly in cholesterol-lowering compounds, highlight his role as a significant inventor. His work continues to influence medical treatments and improve patient health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…